| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |